title: Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
abstract: Topical application of the anti-cholinergic drug ipratropium bromide is used for the treatment of rhinorrhoea. As the commercially-available pressurized aerosols are now largely being replaced by aqueous pump sprays, not containing CFC gases, we have compared these two types of sprays in a time-effect study of 20 normal persons, using the secretory response to nasal methacholine challenge as the effect parameter. Pre-treatment has been given as a single dose of 80 mg of ipratropium bromide, and 24 mg methacholine was used for challenge. The pressurized aerosol reduces rhinorrhoea with 60% (p < 0.05) and the effect lasts for at least 8 h. The corresponding value for the aqueous pump spray is 40% (p < 0.05) and the effect lasts for less than 4 h. The differences between the two sprays is significant 30 min, 1, 2 and 4 h after medication (p < 0.05). This finding is unexpected and we cannot offer a satisfactory explanation. The result indicates that changes in dosing and dose-frequency of ipratropium bromide may be necessary when patients are transferred from a pressurized spray to an aqueous pump spray.
authors.affiliation: Department of Otorhinolaryngology, Glostrup Hospital, Copenhagen, Denmark.
authors.forename: S
authors.initials: S
authors.lastname: Borum
authors.forename: B
authors.initials: B
authors.lastname: Becker
authors.forename: N
authors.initials: N
authors.lastname: Mygind
authors.forename: P
authors.initials: P
authors.lastname: Borum
mesh_terms: D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000704:Analysis of Variance; D005260:Female; D005731:Ganglionic Stimulants; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008688:Methacholine Compounds; D008875:Middle Aged; D009297:Nasal Mucosa / Q000187:drug effects / Q000378:metabolism*; D009299:Nasal Provocation Tests; D012220:Rhinitis / Q000139:chemically induced / Q000188:drug therapy*; D012636:Secretory Rate / Q000187:drug effects; D012996:Solutions
chemical_list: D000336:Aerosols; D005731:Ganglionic Stimulants; D008688:Methacholine Compounds; D012996:Solutions; D009241:Ipratropium